Zimbabwe: Council Decommissions Three Cholera Treatment Centres

Marion Mossing/MSF
Juliet a resident of Glenview, Harare, the epicenter of the cholera outbreak takes the oral cholera vaccine during the mass vaccination campaign that took place in Glenview, Harare recently.
26 July 2024
The Herald (Harare)
By Ivan Zhakata

HARARE City Council has decommissioned three cholera treatment centres (CTC) in the capital that had been designated to ensure prevention protocols were observed.

In a statement, the council said they have decommissioned three CTCs at Kuwadzana Polyclinic, Budiriro Polyclinic and Highfields Polyclinic with the support of World Health Organisation (WHO).

"The decommissioning is a process of systematic dismantling of the CTCs ensuring infection prevention protocols are religiously observed," read the statement.

"The decommissioning has been a result of zero cholera cases being reported in these areas for the past month. We also intend to safely store the CTC materials for future use. We have spared two CTCs in Harare namely at Beatrice Road Infectious Diseases Hospital (BRIDH) and Glen View Polyclinic."

Read the original article on The Herald.

Tagged:
Copyright © 2024 The Herald. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 600 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.